We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

207 hedge funds and large institutions have $1.6B invested in Avadel Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 44 increasing their positions, 72 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $100M | Put options by funds: $45.3M

41% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 49

31% more capital invested

Capital invested by funds: $1.22B → $1.6B (+$376M)

10% more funds holding

Funds holding: 188 → 207 (+19)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

6.83% less ownership

Funds ownership: 82.36% → 75.53% (-6.8%)

39% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 72

Holders
207
Holders Change
+19
Holders Change %
+10.11%
% of All Funds
2.51%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
69
Increased
44
Reduced
72
Closed
49
Calls
$100M
Puts
$45.3M
Net Calls
+$55M
Net Calls Change
+$42.8M

Top Buyers

Rank Fund Capital Flow
1
WAM
Weiss Asset Management
Massachusetts
+$87.7M
2
TAL
TIG Advisors LLC
New York
+$74.9M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$57.1M
4
Fidelity International
Fidelity International
Bermuda
+$54.8M
5
HCM
Highbridge Capital Management
New York
+$39.8M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$109M
2
BIP
Brandes Investment Partners
California
-$101M
3
TSC
Two Seas Capital
New York
-$82M
4
PCH
Polar Capital Holdings
United Kingdom
-$61.1M
5
Morgan Stanley
Morgan Stanley
New York
-$33.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
76
AQR Arbitrage
Connecticut
$2.38M +$2.14M +110,396 New
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$2.32M -$390K -20,074 -16%
State of Wisconsin Investment Board
78
State of Wisconsin Investment Board
Wisconsin
$2.31M -$1.14M -58,608 -35%
PAMP
79
Polar Asset Management Partners
Ontario, Canada
$2.27M +$2.05M +105,399 New
Federated Hermes
80
Federated Hermes
Pennsylvania
$2.19M +$1.91M +98,240 +2,830%
AllianceBernstein
81
AllianceBernstein
Tennessee
$2.12M +$617K +31,776 +48%
Arrowstreet Capital
82
Arrowstreet Capital
Massachusetts
$2.02M +$1.82M +93,528 New
Group One Trading
83
Group One Trading
Illinois
$2M +$429K +22,108 +31%
Millennium Management
84
Millennium Management
New York
$1.81M -$161K -8,315 -9%
IAMOG
85
Investors Asset Management of Georgia
Georgia
$1.79M -$949K -48,900 -37%
California State Teachers Retirement System (CalSTRS)
86
California State Teachers Retirement System (CalSTRS)
California
$1.79M -$90.9K -4,682 -5%
QT
87
Quantbot Technologies
New York
$1.72M +$614K +31,619 +65%
RC
88
Rangeley Capital
Connecticut
$1.64M +$1.47M +75,953 New
Two Sigma Investments
89
Two Sigma Investments
New York
$1.54M +$1.38M +71,336 New
Invesco
90
Invesco
Georgia
$1.47M -$9.21M -474,454 -87%
Los Angeles Capital Management
91
Los Angeles Capital Management
California
$1.42M -$178K -9,164 -11%
Susquehanna International Group
92
Susquehanna International Group
Pennsylvania
$1.33M -$3.46M -178,191 -74%
CL
93
CSS LLC
Illinois
$1.27M +$1.15M +59,037 New
Franklin Resources
94
Franklin Resources
California
$1.27M +$47.9K +2,465 +4%
OQS
95
Occudo Quantitative Strategies
Florida
$1.16M +$1.04M +53,730 New
T. Rowe Price Associates
96
T. Rowe Price Associates
Maryland
$1.12M +$65.9K +3,392 +7%
MIM
97
MetLife Investment Management
New Jersey
$1.09M -$102K -5,253 -9%
SG Americas Securities
98
SG Americas Securities
New York
$1.08M +$978K +50,366 New
Two Sigma Advisers
99
Two Sigma Advisers
New York
$989K +$891K +45,900 New
TAM
100
TFG Asset Management
Cayman Islands
$943K +$850K +43,763 New
2 3
4
5 6

AVDL Hedge Fund Activity: Q4 2025 in Review

207 of the 8,252 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q4 2025, worth a combined $1.6B — up 31% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new AVDL positions and 49 closed out — a net gain of 20 holders — while 44 added to existing stakes and 72 trimmed.

The largest buyer was Weiss Asset Management, opening a new position worth an estimated $87.7M. The largest seller was Janus Henderson Group, cutting an estimated $109M.

  • 207 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q4 2025, up from 188 in Q3 2025.
  • Funds reported $1.6B of Avadel Pharmaceuticals stock for Q4 2025, up 31% quarter-over-quarter.
  • 69 funds opened new Avadel Pharmaceuticals positions in Q4 2025 and 49 closed out, a net change of +20 holders.
  • The largest Avadel Pharmaceuticals buyer in Q4 2025 was Weiss Asset Management, an estimated $87.7M added.
  • The largest Avadel Pharmaceuticals seller in Q4 2025 was Janus Henderson Group, an estimated $109M sold.

Based on aggregated 13F filings for Q4 2025.